Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Central Venous Pressure | 1 | 2010 | 4 | 0.360 |
Why?
|
| Fluid Therapy | 1 | 2010 | 24 | 0.350 |
Why?
|
| Oropharynx | 1 | 2007 | 6 | 0.300 |
Why?
|
| Glottis | 1 | 2007 | 6 | 0.300 |
Why?
|
| Mucous Membrane | 1 | 2007 | 20 | 0.300 |
Why?
|
| Catheterization | 1 | 2007 | 58 | 0.290 |
Why?
|
| Trachea | 1 | 2007 | 52 | 0.290 |
Why?
|
| Postoperative Complications | 3 | 2013 | 780 | 0.250 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2004 | 42 | 0.240 |
Why?
|
| Esophagus | 1 | 2004 | 22 | 0.240 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2013 | 73 | 0.160 |
Why?
|
| Coronary Artery Bypass | 3 | 2013 | 103 | 0.130 |
Why?
|
| Factor IX | 1 | 2013 | 11 | 0.110 |
Why?
|
| Postoperative Hemorrhage | 1 | 2013 | 42 | 0.110 |
Why?
|
| Intensive Care Units | 2 | 2010 | 110 | 0.100 |
Why?
|
| Observer Variation | 1 | 2010 | 105 | 0.090 |
Why?
|
| Aged | 6 | 2013 | 10301 | 0.090 |
Why?
|
| Middle Aged | 6 | 2013 | 11817 | 0.090 |
Why?
|
| Clinical Protocols | 1 | 2010 | 97 | 0.090 |
Why?
|
| Monitoring, Physiologic | 1 | 2010 | 73 | 0.080 |
Why?
|
| Female | 7 | 2013 | 19959 | 0.080 |
Why?
|
| Ranitidine | 1 | 2009 | 2 | 0.080 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2009 | 2 | 0.080 |
Why?
|
| Peptic Ulcer | 1 | 2009 | 4 | 0.080 |
Why?
|
| Catheterization, Central Venous | 1 | 2010 | 62 | 0.080 |
Why?
|
| Adult | 4 | 2013 | 9345 | 0.080 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2009 | 8 | 0.080 |
Why?
|
| Cross Infection | 1 | 2009 | 55 | 0.080 |
Why?
|
| Multiple Trauma | 1 | 2007 | 41 | 0.070 |
Why?
|
| Respiration, Artificial | 1 | 2007 | 98 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 407 | 0.070 |
Why?
|
| Male | 6 | 2013 | 19165 | 0.070 |
Why?
|
| Humans | 7 | 2013 | 32005 | 0.060 |
Why?
|
| Anesthesia, General | 1 | 2004 | 28 | 0.060 |
Why?
|
| Aortic Valve Stenosis | 1 | 2004 | 30 | 0.060 |
Why?
|
| Pipecolic Acids | 1 | 2003 | 6 | 0.060 |
Why?
|
| Thrombocytopenia | 1 | 2003 | 30 | 0.060 |
Why?
|
| Radiography | 1 | 2004 | 376 | 0.050 |
Why?
|
| Heparin | 1 | 2003 | 73 | 0.050 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2002 | 4 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2007 | 918 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 517 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2003 | 122 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 3990 | 0.050 |
Why?
|
| Anesthesia | 1 | 2002 | 64 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2004 | 401 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2004 | 475 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2013 | 1817 | 0.040 |
Why?
|
| Chest Tubes | 1 | 2013 | 5 | 0.030 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2013 | 4 | 0.030 |
Why?
|
| Blood Coagulation Disorders | 1 | 2013 | 13 | 0.030 |
Why?
|
| Antifibrinolytic Agents | 1 | 2013 | 16 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2013 | 3306 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2013 | 3509 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 247 | 0.030 |
Why?
|
| Anti-Ulcer Agents | 1 | 2009 | 3 | 0.020 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2009 | 13 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2009 | 93 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 130 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 158 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 149 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2009 | 191 | 0.020 |
Why?
|
| Reference Values | 1 | 2009 | 246 | 0.020 |
Why?
|
| Age Distribution | 1 | 2009 | 206 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 684 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2009 | 753 | 0.020 |
Why?
|
| Logistic Models | 1 | 2009 | 781 | 0.020 |
Why?
|
| Incidence | 1 | 2009 | 1199 | 0.020 |
Why?
|
| Risk Factors | 1 | 2013 | 3876 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2009 | 2265 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 2003 | 22 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2009 | 1426 | 0.010 |
Why?
|
| Preanesthetic Medication | 1 | 2002 | 3 | 0.010 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2002 | 6 | 0.010 |
Why?
|
| Critical Illness | 1 | 2003 | 87 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2002 | 155 | 0.010 |
Why?
|
| Oxygen | 1 | 2002 | 142 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2002 | 89 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2002 | 107 | 0.010 |
Why?
|